Skip to main content
Erschienen in: Health and Quality of Life Outcomes 1/2016

Open Access 01.12.2016 | Research

The Minnesota living with heart failure questionnaire: comparison of different factor structures

verfasst von: Amaia Bilbao, Antonio Escobar, Lidia García-Perez, Gemma Navarro, Raul Quirós

Erschienen in: Health and Quality of Life Outcomes | Ausgabe 1/2016

Abstract

Background

The Minnesota Living with Heart Failure Questionnaire (MLHFQ) is one of the most widely used health-related quality of life questionnaires for patients with heart failure (HF). It provides scores for two dimensions, physical and emotional, and a total score. However, there are some concerns about its factor structure and alternatives have been proposed, some including a third factor representing a social dimension. The objectives of the present study were to analyze the internal structure of the MLHFQ and the unidimensionality of the total score, and to compare the different factor structures proposed.

Methods

The MLHFQ was given to 2565 patients with HF. The structural validity of the questionnaire was assessed by confirmatory factor analysis (CFA), and Rasch analysis. These two approaches were also applied to the alternative structures proposed.

Results

The CFA results for the hypothesized model of two latent factors and the Rasch analysis confirmed the adequacy of the physical and emotional scales. Rasch analysis for the total score showed only two problematic items. The results of the CFA for other two-factor structures proposed were not better than the results for the original structure. The Rasch analyses applied to the different social factors yielded the best results for Munyombwe’s social dimension, composed of six items.

Conclusions

Our results support the validity of using the MLHFQ physical, emotional and total scores in patients with HF, for clinical practice and research. In addition, they confirmed the existence of a third factor, and we recommend the use of Munyombwe’s social factor.
Hinweise

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

AB has participated in the conception and design of the study, in the analysis and interpretation of data, and has been involved in drafting the manuscript; AE, LGP, GN and RQ have participated in the conception, design, acquisition of data, and coordination of the study, have helped to draft the manuscript and have been involved in revising it critically for important content. All authors have read and approved the final manuscript.
Abkürzungen
AIC
Akaike Information Criterion
CFA
Confirmatory factor analysis
CFI
Comparative Fit Index
CTT
Classical test theory
DIF
Differential item functioning
EFA
Exploratory factor analysis
HF
Heart failure
HRQoL
Health-related quality of life
INFIT
Mean square information-weighted statistic
IRT
Item response theory
MCS
Mental Component Summary
MLHFQ
Minnesota Living with Heart Failure Questionnaire
OUTFIT
Outlier-sensitive statistic
PCA
Principal component analysis
PCS
Physical Component Summary
RMSEA
Root mean square error of approximation
SD
Standard deviation
SF-12
12-item Short Form Health Survey
TLI
Tucker-Lewis Index

Background

Heart failure (HF) is one of the most important health problems in terms of prevalence, morbidity, mortality and health service use [1]. It affects around 2 to 3 % of the population and the prevalence increases with age, affecting as much as around 10 to 20 % of the population over 65 years old [13]. In developed countries, the prevalence of HF is increasing due to population aging, longer survival of patients and effectiveness of secondary prevention [4, 5]. Projections indicate that the prevalence of HF will increase as much as 46 % from 2012 to 2030 [1]. In brief, HF is a common disease with a huge impact on the prognosis and lifestyle of patients and a growing challenge for health policy makers [6].
The health-related quality of life (HRQoL) of patients with HF is an important outcome as it reflects the impact of HF on their daily lives [7, 8]. Instruments to assess HRQoL provide a way to explore the perceptions of patients about how HF affects their daily lives and wellbeing, providing information that cannot be obtained directly from clinical measurements [5]. In recognition of this, improving the HRQoL has emerged as an important treatment goal [4, 9, 10].
Various specific HRQoL questionnaires for patients with HF have become regarded as important assessment tools in recent decades [2, 5, 11, 12]. Among these, one of the most widely known and used is the Minnesota Living with Heart Failure Questionnaire (MLHFQ) [10, 11, 13], which has been translated and culturally adapted into at least 34 languages, and has demonstrated good psychometric properties in numerous studies [2, 5, 7, 11, 1420]. However, there are some concerns about its factor structure and the homogeneity of items [7, 10, 13, 17]. Several authors have even proposed different factor structures [4, 7, 15, 18, 21]. When reviewing validation studies, we encountered certain problems and weaknesses. Firstly, while some authors obtained similar factor structures to the original developers of the questionnaire [18, 22, 23], others obtained two-factor structures but disagreed on certain items [7], and various even extracted structures of three factors, with a new social subscale [4, 15, 16, 18, 21], but disagree on the items that make up the third factor. Secondly, in clinical practice, the MLHFQ is commonly used to generate a total score, which assumes that the total scale is unidimensional, but we found only two studies analyzing a single-factor structure [15, 18], and they differ in their conclusions. Lastly, most studies that analyze the structural validity of the instrument have been carried out from the perspective of classical test theory (CTT) [4, 7, 1619, 21, 22], and more specifically, using techniques of exploratory factor analysis (EFA) rather than confirmatory factor analysis (CFA). Considering all this, we posed the following questions. Is the total score unidimensional? Does the questionnaire have a two-factor structure? Or is there a third factor representing a social dimension? And if so, which of the social factors proposed is the most appropriate?
Therefore, the objectives of the present study were: 1) to conduct a validation study of the MLHFQ, analyzing the internal structure using both CTT and item response theory (IRT); 2) to compare different factor structures proposed by other authors; and 3) to assess other psychometric properties including known-groups validity, convergent validity, and reliability of the different social factors proposed.

Methods

Study population

The current study included patients recruited from 13 participating hospitals of the Spanish National Health Service between December 2008 and May 2013. Consecutive patients hospitalized for HF in cardiology or internal medicine departments of the participating hospitals during the study period were invited to participate. Patients were excluded if they had any organic or psychiatric disorder that might hinder completion of questionnaires. The study was approved by the corresponding institutional review boards.

Measurements

All eligible patients were given a letter informing them about the study and asking for their voluntary participation. In addition, they were given the MLHFQ [13], and the 12-item Short Form Health Survey (SF-12) [24, 25] for completion during hospitalization. Six months after hospitalization, the same questionnaires were sent by mail to patients at home for completion and return by mail. A reminder letter was sent to patients who had not replied within 15 days. Sociodemographic and clinical data were also collected.
The MLHFQ is a self-administered disease-specific questionnaire for patients with HF [13], comprising 21 items rated on six-point Likert scales, representing different degrees of impact of HF on HRQoL, from 0 (none) to 5 (very much). It provides a total score (range 0–105, from best to worst HRQoL), as well as scores for two dimensions, physical (8 items, range 0–40) and emotional (5 items, range 0–25). The other eight items (of the total of 21) are only considered for the calculation of the total score. The MLHFQ has been translated into and validated in Spanish [5, 19].
The SF-12 is a generic questionnaire for assessing HRQoL [24, 25] comprising 12 items and two summary scales: the physical and mental component summary (PCS and MCS). The scores for these components range from 0 to 100, with higher scores indicating better health status. The SF-12 has been translated into and validated in Spanish [26].

Statistical analysis

The unit of analysis was the patient. If patients had more than one hospitalization during the study period, only the first was considered. The descriptive statistical analysis was based on frequency tables, and means and standard deviations (SDs).

Construct validity

To study the structural validity of the questionnaire, two different approaches were used. First, CFA for categorical data was used to confirm the hypothesis that 13 items on the questionnaire reflected two dimensions, physical and emotional, as proposed by the original developers [13]. Second, Rasch analysis within IRT models was used to assess each specific dimension of the questionnaire, as well as the total scale, for unidimensionality. These two approaches were also applied to different factor structures proposed by other authors [4, 7, 15, 16, 18, 21], to compare the structures (Appendix 1).
Regarding the CFA, the robust unweighted least squares estimator was used, and three fit indices were calculated [2731]: the root mean square error of approximation (RMSEA), for which a value <0.08 was considered acceptable; and the Tucker-Lewis Index (TLI) and Comparative Fit Index (CFI), for both of which >0.90 was considered acceptable. We also examined factor loadings, and those ≥0.40 were considered acceptable. For the comparison of different factor structures, as the models are non-nested, we used the Akaike Information Criterion (AIC), with lower values indicating a better fit.
In relation to the IRT models, we used the polytomous Rasch rating scale model because the response scales of the questionnaire are ordinal with six response options [3235]. We applied the Rasch method to the total score and each specific dimension separately to check whether the scales were unidimensional [36] as this is a fundamental requirement for construct validity [37]. Unidimensionality was assessed with two fit indices, namely the mean square information-weighted statistic (infit) and the outlier-sensitive statistic (outfit), with values between 0.7 and 1.3 indicating a good fit [38], and a principal component analysis (PCA) of the residuals. Unidimensionality was considered violated if, besides the first factor, other factors had eigenvalues >3 [39]. We evaluated the ability of the MLHFQ to define a distinct hierarchy of items along each measured dimension by means of an item separation index [36]. A value of >2.0 is comparable to a reliability of 0.80 and considered acceptable. To detect the presence of differential item functioning (DIF), which occurs when different groups within the sample respond in a different manner to an individual item [32], we compared different levels of the trait by sex and age group (≤65 vs. >65 years). A Welch’s t statistically significant at P < 0.05, and a difference in difficulty of ≥0.5 logit were considered to be noticeable DIF [39]. Residuals correlations between items within a scale were examined for local dependency. Correlations >0.5 between item residuals may indicate that responses to one item may be determined by those to another [40]. The functioning of rating scale categories was also examined for each item. A clearly progressive level of difficulty across the item categories was considered adequate [39].

Convergent validity

We assessed convergent validity of the different social factors by analyzing the relationship between the MLHFQ social scale and SF-12 scores with Spearman’s correlation coefficient.

Known-groups validity

Known-groups validity of the different social factors was examined by comparing the MLHFQ social subscale scores 6 months after discharge among groups based on whether or not the patient had (a) attended the emergency department or (b) had any readmissions during the previous 6 months. For this analysis, we used data from the 6-month follow-up, and we used t-tests or non-parametric Wilcoxon tests. We hypothesized that patients who had attended the emergency department or had any readmissions would obtain worse MLHFQ social scores at 6 months. Furthermore, to assess the magnitude of group differences, the effect size was calculated as the mean difference divided by the pooled standard deviation. Cohen’s benchmarks were used to classify the magnitude of effect sizes: <0.20 being considered not significant; 0.20 to 0.49 small, 0.50 to 0.79 moderate, and ≥0.80 large [41].

Reliability

We assessed internal consistency using Cronbach’s alpha coefficient [42]. A coefficient >0.70 was considered acceptable [43].
All effects were considered statistically significant at P < 0.05. The statistical analyses were performed with SAS for Windows (version 9.2; SAS Institute, Cary, NC), Mplus (version 6.1; Muthén et al., 1998–2010), and Winsteps (version 3.69.1.4; John M. Linacre, Chicago).

Results

During the recruitment period, 2565 patients hospitalized for HF fulfilled the selection criteria, agreed to participate and completed the baseline questionnaires. Of these, 1211 (47.21 %) completed the questionnaires 6 months after discharge. Table 1 shows descriptive statistics for the sociodemographic, clinical and HRQoL data at baseline.
Table 1
Sociodemographic and clinical variables, and baseline MLHFQ and SF-12 scores: descriptive statistics of the sample (N = 2565)
Parameter
n (%)
Age, mean (SD)
77.25 (10.21)
Sex, men
1291 (50.33)
Body mass index (kg/m2)
 
 BMI < 25
234 (20.47)
 25 ≤ BMI < 30
426 (37.27)
 30 ≤ BMI < 35
299 (26.16)
 BMI ≥35
184 (16.10)
Smoking history
 
 No
1232 (58.17)
 Ex
710 (33.52)
 Yes
176 (8.31)
Left ventricular ejection fraction
 
 ≤45 %
888 (39.15)
 >45 %
1380 (60.85)
NYHA classification at discharge
 
 I
89 (3.62)
 II
1306 (53.07)
 III
1021 (41.49)
 IV
45 (1.83)
Charlson comorbidity index
 
 0
173 (6.88)
 1
500 (19.90)
 2
578 (23)
 3
484 (19.26)
 >3
778 (30.96)
MLHFQ score, mean (SD)
 
 Physical subscale
27.40 (9.05)
 Emotional subscale
12.40 (7.28)
 Total scale
57.85 (22.69)
SF-12 score, mean (SD)
 
 Physical Component Summary
29.30 (8.91)
 Mental Component Summary
41.55 (11.36)
Data are expressed as frequency (percentage) unless otherwise stated. Percentages exclude patients with missing data
SD Standard deviation, BMI Body mass index, NYHA New York Heart Association
The scores for the MLHFQ physical subscale range from 0 to 40, the emotional subscale from 0 to 25, and the total scale from 0 to 105, with higher scores indicating worse health status. The scores for the SF-12 domains range from 0 to 100, with higher scores indicating better health status

Construct validity

The results of the CFA for the hypothesized model of two latent factors, physical and emotional, provided satisfactory fit indices (Table 2). The RMSEA value was around 0.08, and CFI and TLI values both exceeded 0.90. All factor loadings were statistically significant (P < 0.001) and >0.40 (Fig. 1).
Table 2
Results of fit indices of confirmatory factor analysis of the different MLHFQ structures (N = 2565)
Models (first author)
No. of factors
χ2 (df)
RMSEA (90 % CI)
CFI
TLI
Factor loading (Range)
AIC
2-factor models
       
 Rector
2
1002.34 (60)
0.083 (0.079 − 0.088)
0.970
0.961
0.61 − 0.88
1064.34
 Heo
2
1100.03 (85)
0.080 (0.076 – 0.084)
0.966
0.958
0.50 – 0.87
1170.03
3-factor models
       
 Ho
3
3011.42 (145)
0.103 (0.100 − 0.106)
0.909
0.892
0.35 − 0.86
3101.42
 Moon
3
3711.48 (182)
0.102 (0.099 − 0.105)
0.903
0.888
0.34 − 0.86
3809.48
 Lambrinou
3
2351.97 (144)
0.091 (0.087 − 0.094)
0.929
0.916
0.32 − 0.89
2483.97
 Garin
3
1414.26 (112)
0.079 (0.075 − 0.083)
0.952
0.942
0.43 − 0.89
1496.26
 Munyombwe
3
2687.35 (163)
0.091 (0.088 − 0.094)
0.927
0.914
0.35 − 0.87
2781.35
χ 2 Chi-square, df degrees of freedom, RMSEA root mean square error of approximation, CI Confidence interval, CFI comparative fit index, TLI Tucker-Lewis fit index, AIC Akaike information criterion
Regarding the results of the Rasch analysis for the physical and emotional dimensions, and the total score (Table 3), the unidimensionality was supported with infit and outfit statistics of 0.7 to 1.3, except in three items of the physical dimension: item 3 with an outfit value slightly below 0.7, item 7 with infit and outfit values slightly above 1.30, and item 6 with infit and outfit values above 1.30 (infit = 1.54 and outfit = 1.69); and the following items of the total score: items 8 and 10 with fit statistics substantially above 1.3; item 1 with an infit value slightly above 1.3 but an outfit value of 1.82; item 2 with an infit value slightly below 0.7; and item 13 with both fit statistics slightly below 0.7. However, the PCA of the residuals did not yield additional factors with eigenvalues >3, implying that the unidimensionality assumption was met. The item separation indices were >2, indicating reliability of >0.80. The presence of DIF was not detected by sex or age group, except in item 10 for the total score, this item being more difficult for men than women and for patients ≤65 years than those >65 years. Correlation coefficients between residuals were all <0.50, supporting the assumption of local independence, and the functioning of the rating scale categories was adequate.
Table 3
Severity levels, standard errors, and goodness-of-fit indices of the MLHFQ specific dimensions and the total score using Rasch analysis (N = 2565)
Items
Item description
δ (logit)
SE
Infit MNSQ
Outfit MNSQ
Physical
     
 Item 7
Relating to or doing things with friends or family difficult
1.20
0.02
1.34
1.37
 Item 6
Sleeping difficult
0.50
0.02
1.54
1.69
 Item 2
Resting during day
0.12
0.02
0.79
0.88
 Item 4
Working around house difficult
−0.15
0.02
1.12
1.08
 Item 12
Shortness of breath
−0.27
0.02
1.08
1.12
 Item 5
Being away from home difficult
−0.41
0.02
0.86
0.80
 Item 13
Fatigue
−0.46
0.02
0.81
0.77
 Item 3
Walking or climbing stairs difficult
−0.53
0.02
0.72
0.67
Emotional
     
 Item 17
Feeling burden to family or friends
0.48
0.02
1.05
0.99
 Item 18
Feeling a loss of self-control
0.24
0.02
0.82
0.79
 Item 20
Difficulty concentrating or remembering
0.22
0.02
1.24
1.25
 Item 21
Being depressed
−0.22
0.02
0.98
0.96
 Item 19
Being worried
−0.73
0.02
0.95
0.88
Total
     
 Item 16
Side effects from medications
0.80
0.02
1.13
1.17
 Item 10
Sexual activities difficult
0.65
0.02
1.84
1.91
 Item 15
Medical costs
0.57
0.02
1.02
1.03
 Item 8
Working to earn a living difficult
0.44
0.02
1.86
1.97
 Item 17
Feeling burden to family or friends
0.42
0.01
0.94
0.91
 Item 7
Relating to or doing things with friends or family difficult
0.35
0.01
0.75
0.72
 Item 18
Feeling a loss of self-control
0.29
0.01
0.75
0.72
 Item 20
Difficulty concentrating or remembering
0.28
0.01
1.02
1.17
 Item 11
Eat less food you like
0.19
0.01
1.03
1.15
 Item 9
Recreational activities difficult
0.05
0.01
1.07
1.05
 Item 21
Being depressed
0.03
0.01
0.82
0.84
 Item 1
Swelling in your ankles, legs
−0.07
0.01
1.37
1.82
 Item 6
Sleeping difficult
−0.08
0.01
1.06
1.21
 Item 14
Hospitalization
−0.20
0.02
1.11
1.17
 Item 19
Being worried
−0.26
0.02
0.83
0.81
 Item 2
Resting during day
−0.32
0.02
0.68
0.76
 Item 4
Working around house difficult
−0.49
0.02
1.03
1.04
 Item 12
Shortness of breath
−0.57
0.02
0.83
0.86
 Item 5
Being away from home difficult
−0.66
0.02
0.87
0.88
 Item 13
Fatigue
−0.69
0.02
0.66
0.61
 Item 3
Walking or climbing stairs difficult
−0.74
0.02
0.75
0.72
Social proposed by Lambrinou
    
 Item 10
Sexual activities difficult
0.40
0.02
1.21
1.03
 Item 8
Working to earn a living difficult
0.09
0.02
0.97
0.87
 Item 9
Recreational activities difficult
−0.49
0.02
0.80
0.85
Social proposed by Garin
    
 Item 10
Sexual activities difficult
0.24
0.02
1.03
0.90
 Item 15
Medical costs
0.16
0.02
1.33
1.43
 Item 8
Working to earn a living difficult
0.01
0.02
0.97
0.87
 Item 9
Recreational activities difficult
−0.41
0.02
0.68
0.67
Social proposed by Munyombwe
    
 Item 16
Side effects from medications
0.40
0.02
0.97
0.95
 Item 10
Sexual activities difficult
0.25
0.02
1.14
1.03
 Item 15
Medical costs
0.18
0.01
0.92
0.88
 Item 8
Working to earn a living difficult
0.06
0.02
1.21
1.11
 Item 9
Recreational activities difficult
−0.31
0.01
0.81
0.78
 Item 14
Hospitalization
−0.57
0.02
1.10
1.10
δ level of severity (higher values indicate higher severity), SE standard error, MNSQ mean square fit statistic.
Item separation index of each model: 25.31 for the MLHFQ physical dimension, 21.08 for the MLHFQ emotional dimension, 18.01 for the social dimension proposed by Lambrinou, 14.63 for the social dimension proposed by Garin, 20.96 for the social dimension proposed by Munyombwe, and 27.18 for the MLHFQ total scale

Comparison of different factor structures

The results of the CFA applied to other factor structures proposed (Appendix 1) are shown in Table 2. The results for the two-factor structure proposed by Heo et al. [7] (hereinafter referred to as Heo’s structure) are satisfactory (RMSEA = 0.08; CFI, TLI > 0.95; range of factor loadings, 0.50 − 0.87). The remaining factor structures considered are three-factor models. Among them, the models proposed by Ho et al. [14] and Moon et al. [4] (Ho’s and Moon’s structures, respectively) obtained unsatisfactory fit, with RMSEA values >0.1, TLIs <0.90, and some factor loadings <0.40. Among the other three-factor models, the best results were obtained with the model proposed by Garin et al. [18] (Garin’s structure). In the models proposed by Lambrinou et al. [21] and Munyombwe et al. [19] (Lambrinou’s and Munyombwe’s structures, respectively), although fit indices were satisfactory, some items showed factor loadings <0.40. Considering the AIC values, the factor structure proposed by the original developers [13] provided the best results among the two-factor models, and Garin’s structure [18] the best results among the three-factor models.
Among the different social factors proposed in the three-factor models, we compared those in Garin’s, Lambrinou’s and Munyombwe’s structures using Rasch analysis (Table 3). The results supported the unidimensionality of Lambrinou’s and Munyombwe’s social dimensions. In the case of the Garin’s social dimension, we found that item 9 had an outfit value slightly below 0.7, and item 15 had both infit and outfit values above 1.3. In all three social dimensions, the item separation index considerably exceeded the minimum required of 2 (18.01, 14.63, and 20.96, respectively). The presence of DIF by sex or age was not detected in any of the social dimensions, and the functioning of the rating scale categories was adequate. Local dependency was found between items 9 and 10 (r = 0.51) and items 8 and 10 (r = 0.50) in Lambrinou’s social dimension, and between items 8 and 15 (r = 0.51) in that proposed by Garin, but not between any items of Munyombwe’s social dimension.
Regarding convergent validity of the social dimensions, SF-12 domain scores were more strongly correlated with Munyombwe’s social dimension than the others (Table 4). Known-groups validity was supported for all social dimensions, patients who attended the emergency department or had any readmissions in the previous 6 months reporting significantly higher MLHFQ social scores (P < 0.0001). However, the effect size was much higher for Munyombwe’s social dimension than for the others. Cronbach’s alpha coefficients for the social dimensions proposed by Lambrinou, Garin and Munyombwe were 0.75, 0.71, and 0.76, respectively.
Table 4
Correlation between the MLHFQ social subscales and SF-12 components, and known-groups validity of the MLHFQ social subscales
 
MLHFQ
 
Social subscale proposed by
 
Lambrinou
Garin
Munyombwe
 
ρ coefficient
ρ coefficient
ρ coefficient
SF-12
   
 Physical Component Summary
−0.24
−0.31
−0.38
 Mental Component Summary
−0.31
−0.37
−0.41
 
Mean (SD)
Mean (SD)
Mean (SD)
Attended emergency department during the previous 6 months
   
 Yes (n = 239)
7.57 (5.50)
9.58 (6.38)
13.09 (8.54)
 No (n = 724)
4.98 (5.09)
6.23 (5.92)
7.84 (7.18)
P value
<0.0001
<0.0001
<0.0001
 Effect size
0.49
0.54
0.67
Readmission during the previous 6 months
   
 Yes (n = 302)
7.29 (5.43)
9.30 (6.40)
13.09 (8.36)
 No (n = 674)
4.94 (5.10)
6.11 (5.88)
7.42 (6.97)
P value
<0.0001
<0.0001
<0.0001
 Effect size
0.44
0.51
0.72
ρ: Spearman correlation coefficient, SD Standard deviation
Data are expressed as the Spearman correlation coefficient when studying the correlation between the MLHFQ social subscales and SF-12 components, and as the mean (SD) when comparing the MLHFQ social subscales as a function of emergency department attendance, or readmission during the previous 6 months
The scores for the social dimension range from 0 to 15 for that proposed by Lambrinou, from 0 to 20 for that proposed by Garin, and from 0 to 30 for that proposed by Munyombwe, with higher scores indicating worse health status. The scores for the SF-12 dimensions range from 0 to 100, with higher scores indicating better health status

Discussion

The results of the current prospective study with a large cohort of patients hospitalized for HF at different hospitals support the validity and reliability of the MLHFQ, and most importantly, support the unidimensionality of the MLHFQ total score and the existence of a third factor, a social dimension, with good psychometric properties. To the best of our knowledge, this is the first study that compares different MLHFQ factor structures; this approach is a strength of the research in that it helps us to explore whether the original MLHFQ factor structure is valid, and to assess which of the different social factors proposed is the most appropriate.
Another strength is that we have conducted a complete study of the structural validity, using both confirmatory techniques of CTT, such as CFA, and IRT-based Rasch analysis. Most studies have assessed the structural validity of this questionnaire from the perspective of CTT [4, 7, 1619, 21, 22], and more specifically, using EFA rather than CFA techniques. Once an instrument has been translated into another language and culturally adapted for the target population, its structure should be confirmed by CFA. We only found two studies in which CFA was conducted [15, 23], one of them using a sample of just 50 patients [23], and we only found one study on the structural validity of the instrument combining both CTT- and IRT-based methods [18].
Regarding two-factor structures, reviewing MLHFQ validation studies, we identified several problems and weaknesses. Specifically, several authors have questioned the factor structure of the questionnaire [2, 5, 7, 11, 1420]. Our CFA results indicate that the original structure of the questionnaire does have adequate structural validity. Considering the results of Rasch analysis for the physical factor, we found only item 6 to be misfitting. Munyombwe et al. [18], in the only study in which an IRT model is applied to the questionnaire, did not find this item to be problematic in the Rasch analysis, but unlike us, they detected DIF by sex in item 3. None of the other studies that proposed different factor structures [4, 7, 15, 16, 18, 21] drop item 6 from the physical factor. Further, taking into account the satisfactory results obtained from the rest of the Rasch analysis and the satisfactory CFA results, we do not consider that the identification of this item as misfitting is sufficient reason to conclude that this item should be excluded from the physical dimension. Regarding the emotional MLHFQ dimension, the fit indices from Rasch method support unidimensionality and provide strong evidence of construct validity. Munyombwe et al. [18] also found satisfactory results in the Rasch analysis applied to this dimension.
Concerning different factor structures that have been proposed [4, 7, 15, 16, 18, 21], in general, there is consensus about the emotional factor, all but one study agreeing on the constituent items [21]. The largest discrepancies are related to the items that make up the physical factor, and the fact that three-factor structures have emerged in some studies, the new factor corresponding to a social dimension [4, 15, 16, 18, 21]. In relation to the two-factor structures considered, Heo et al. [7] proposed a physical factor which includes the same items as the original developers and adds two more items, item 1 and item 9, maintaining the same emotional factor. Other authors have also proposed that item 1 be included in the physical factor [4, 15, 16, 18]; however, when comparing our CFA results for Heo’s model with those for the original model [7], we obtain slightly better results for the latter. Hence, we rule out Heo’s model as an alternative to the original.
In relation to the physical factor suggested by other authors (Appendix 1), Ho and Moon both proposed a factor with somewhat larger discrepancies with the original. Further, we found the worst CFA results for these two proposals. Among the other structures, the composition of the physical factor differs only in one or two items. However, as noted previously [15], the modification of an instrument is not easy. Besides, in the case of this questionnaire, the new structures that have been proposed are generally obtained from EFA and not CFA [15], and on the other hand, the widespread use of the questionnaire means that changes would be difficult to implement and would also hinder comparability with existing data. Consequently, and considering that the results from both CTT and IRT for this factor were satisfactory, we see no need to establish a different composition for the physical factor.
With respect to a potential third factor, representing a social dimension, adding a third factor would not be as complicated as changing the composition of existing factors, since it would not involve any change to what was established by the original developers [13] or affect comparability with other studies. However, it is important to reach a consensus on which of the different social factors proposed is the most appropriate and has the best psychometric properties [4, 15, 16, 18, 21]. Although several authors have proposed such a third factor, none of them have studied the properties of the factor from the perspective of IRT, or using confirmatory techniques. In our analysis, the Ho and Moon social factors were considered inadequate, having fit indices below the minimum required, and obtained the highest AIC values. Furthermore, they included items of the physical factor proposed by the original developers in their social factor, implying a complete change of structure. The remaining proposals for a social factor only disagree on a few items. All of them considered items 8, 9 and 10; Garin also included item 15; and Munyombwe, besides item 15, includes items 14 and 16. Regarding the results of the CFA, the lowest AIC value was obtained for Garin’s factor. However, to compare the three social factors, it is also necessary to consider the IRT results, because in the CFA we are analyzing the complete structure of the questionnaire and not just the social factor. Rasch analysis results are satisfactory for all three structures, although Munyombwe’s model is the only one that met all the requirements to be considered an acceptable model. Further, regarding convergent validity, known-groups validity, and reliability, the best results were found for Munyombwe’s social dimension, with the highest correlation coefficients with the SF-12 components, the highest ES in known-groups validity, and the highest Cronbach’s alpha coefficient.
Lastly, the MLHFQ is commonly used to generate a total score, which assumes that the total scale is unidimensional. However, we found only two previous studies [15, 18] that had explored the existence of a single factor, and they differ in their conclusions. The first one [15] applied CFA within a bifactor model and the results confirmed the unidimensionality of the total score. The other study [18] applied Rasch analysis to study the dimensionality of the total factor, and authors concluded that there were some misfitting items, namely, items 7, 8, 10, 14 and 15. They also found DIF by age in items 1 and 8, and by sex in item 3. Regarding misfitting items, Heo et al. [7] concluded that items 8, 10, 14, 15 and 16 were problematic. Another study [44] also stated that items 8, 10 and 15 were problematic, since they were not applicable to all patients. In our case, we only found two items to be markedly misfitting, items 8 and 10, with infit and outfit values well above the threshold. In item 1, we also found some degree of misfit with an outfit of 1.82, and in item 10, DIF was detected by sex and age, men and younger patients finding this item more difficult than women and older patients. Therefore, we confirm the existence of some problematic items in the composition of the total score, but unlike some previous authors [18], we did not detect problems in the functioning of the rating scale categories. As Munyombwe et al. [18] stated, the fact that there are misfitting items does not necessarily imply the need to remove them from the questionnaire, above all when these items would be included in the social factor. Considering a third factor, most of the 21 items would be included in a factor, and hence considering factor scores for the three-factor structure could be an alternative to the total score.
This study has some limitations that should be taken into account. The sample is composed of patients in Spain and we used the Spanish version of the questionnaire, and hence the results may not be generalizable to other populations or other language versions. Moreover, besides having to be valid and reliable, an instrument must also be responsive to changes to be useful. To the best of our knowledge, although there are some studies on the responsiveness of physical, emotional and total scores, the responsiveness of the social factor proposed has not yet been explored.

Conclusions

In conclusion, this comprehensive validation process, which used a large patient sample and combined classical and contemporary methods, supports the validity of MLHFQ physical and emotional subscales in patients with HF, showing good properties from both CTT- and IRT-based perspectives. In addition, the results confirmed the existence of a third factor, and we recommend the use of Munyombwe’s social factor, since it has good psychometric properties, the best among the social factors proposed. On the other hand, we found some problematic items within the total score, implying that it should be used with caution. Moreover, given the validity of the social factor, 19 of the 21 items would be included in a factor, and consequently, factor scores for the three-factor structure could be an alternative to the total factor. In conclusion, this study provides strong evidence that the MLHFQ is useful for measuring HRQoL in patients with HF, and it can be used both in clinical practice and research.
The study was approved by each corresponding institutional review board. All patients were given a letter informing them about the study and asking for their voluntary participation.

Acknowledgements

We are grateful to colleagues in the participating hospitals for their support and to all patients for their collaboration. We acknowledge help provided by the Biostatistics Research Group (Biostit), supported by the Department of Education, Linguistics Policy and Culture of the Basque Government (Ref: IT620-13). The authors also acknowledge editorial assistance provided by Ideas Need Communicating Language Services, through the translation and edition service of the Basque Foundation for Health Innovation and Research (BIOEF).

Financial support

This study was supported in part by grants from the Carlos III Health Institute (Refs: PS09/01129, PS09/00865, PS09/01053, and PS09/01770), the Department of Health of the Basque Government (Ref: 2008111017), and the European Regional Development Fund.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

AB has participated in the conception and design of the study, in the analysis and interpretation of data, and has been involved in drafting the manuscript; AE, LGP, GN and RQ have participated in the conception, design, acquisition of data, and coordination of the study, have helped to draft the manuscript and have been involved in revising it critically for important content. All authors have read and approved the final manuscript.
Anhänge

Appendix

Table 5
Summary of MLHFQ different factor structures proposed
First author
Physical
Emotional
Social
 
No. of items
Items
No. of items
Items
No. of items
Items
Rector, 1992 [10]
8
Q2, Q3, Q4, Q5, Q6, Q7, Q12, Q13
5
Q17, Q18, Q19, Q20, Q21
  
Heo, 2005 [7]
10
Q1, Q2, Q3, Q4, Q5, Q6, Q7, Q9, Q12, Q13
5
Q17, Q18, Q19, Q20, Q21
  
Ho, 2007 [16]
8
Q1, Q2, Q3, Q6, Q11, Q12, Q13, Q16
5
Q17, Q18, Q19, Q20, Q21
6
Q4, Q5, Q7, Q8, Q9, Q10
Moon, 2012 [4]
12
Q1, Q2, Q3, Q4, Q5, Q6, Q9, Q10, Q11, Q12, Q13, Q16
5
Q17, Q18, Q19, Q20, Q21
4
Q7, Q8, Q14, Q15
Lambrinou, 2013 [21]
11
Q2, Q3, Q4, Q5, Q6, Q7, Q9, Q11, Q12, Q13, Q14
6
Q1, Q16, Q18, Q19, Q20, Q21
3
Q8, Q9, Q10
Garin, 2013 [15]
8
Q1, Q2, Q3, Q4, Q5, Q6, Q12, Q13
5
Q17, Q18, Q19, Q20, Q21
4
Q8, Q9, Q10, Q15
Munyombwe, 2014 [18]
9
Q1, Q2, Q3, Q4, Q5, Q6, Q7, Q12, Q13
5
Q17, Q18, Q19, Q20, Q21
4
Q8, Q9, Q10, Q14, Q15, Q16
Literatur
1.
Zurück zum Zitat Go AS, Mozaffarian D, Roger VL, et al. Executive summary: heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation. 2014;129(3):399–410.CrossRefPubMed Go AS, Mozaffarian D, Roger VL, et al. Executive summary: heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation. 2014;129(3):399–410.CrossRefPubMed
2.
Zurück zum Zitat Garin O, Ferrer M, Pont A, et al. Disease-specific health-related quality of life questionnaires for heart failure: a systematic review with meta-analyses. Qual Life Res. 2009;18(1):71–85.CrossRefPubMed Garin O, Ferrer M, Pont A, et al. Disease-specific health-related quality of life questionnaires for heart failure: a systematic review with meta-analyses. Qual Life Res. 2009;18(1):71–85.CrossRefPubMed
3.
Zurück zum Zitat Swedberg K, Cleland J, Dargie H, et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J. 2005;26(11):1115–40.CrossRefPubMed Swedberg K, Cleland J, Dargie H, et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J. 2005;26(11):1115–40.CrossRefPubMed
4.
Zurück zum Zitat Moon JR, Jung YY, Jeon ES, et al. Reliability and validity of the Korean version of the Minnesota Living with Heart Failure Questionnaire. Heart Lung. 2012;41(1):57–66.CrossRefPubMed Moon JR, Jung YY, Jeon ES, et al. Reliability and validity of the Korean version of the Minnesota Living with Heart Failure Questionnaire. Heart Lung. 2012;41(1):57–66.CrossRefPubMed
5.
Zurück zum Zitat Garin O, Soriano N, Ribera A, et al. Validation of the Spanish version of the Minnesota Living with Heart Failure Questionnaire. Rev Esp Cardiol. 2008;61(3):251–9.CrossRefPubMed Garin O, Soriano N, Ribera A, et al. Validation of the Spanish version of the Minnesota Living with Heart Failure Questionnaire. Rev Esp Cardiol. 2008;61(3):251–9.CrossRefPubMed
6.
Zurück zum Zitat Quittan M, Wiesinger GF, Crevenna R, et al. Cross-cultural adaptation of the Minnesota Living with Heart Failure Questionnaire for German-speaking patients. J Rehabil Med. 2001;33(4):182–6.CrossRefPubMed Quittan M, Wiesinger GF, Crevenna R, et al. Cross-cultural adaptation of the Minnesota Living with Heart Failure Questionnaire for German-speaking patients. J Rehabil Med. 2001;33(4):182–6.CrossRefPubMed
7.
Zurück zum Zitat Heo S, Moser DK, Riegel B, et al. Testing the psychometric properties of the Minnesota Living with Heart Failure questionnaire. Nurs Res. 2005;54(4):265–72.CrossRefPubMed Heo S, Moser DK, Riegel B, et al. Testing the psychometric properties of the Minnesota Living with Heart Failure questionnaire. Nurs Res. 2005;54(4):265–72.CrossRefPubMed
8.
Zurück zum Zitat Westlake C, Dracup K, Creaser J, et al. Correlates of health-related quality of life in patients with heart failure. Heart Lung. 2002;31(2):85–93.CrossRefPubMed Westlake C, Dracup K, Creaser J, et al. Correlates of health-related quality of life in patients with heart failure. Heart Lung. 2002;31(2):85–93.CrossRefPubMed
9.
Zurück zum Zitat Alla F, Briancon S, Guillemin F, et al. Self-rating of quality of life provides additional prognostic information in heart failure. Insights into the EPICAL study. Eur J Heart Fail. 2002;4(3):337–43.CrossRefPubMed Alla F, Briancon S, Guillemin F, et al. Self-rating of quality of life provides additional prognostic information in heart failure. Insights into the EPICAL study. Eur J Heart Fail. 2002;4(3):337–43.CrossRefPubMed
10.
Zurück zum Zitat Rector TS, Cohn JN. Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. Pimobendan Multicenter Research Group. Am Heart J. 1992;124(4):1017–25.CrossRefPubMed Rector TS, Cohn JN. Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. Pimobendan Multicenter Research Group. Am Heart J. 1992;124(4):1017–25.CrossRefPubMed
11.
Zurück zum Zitat Garin O, Herdman M, Vilagut G, et al. Assessing health-related quality of life in patients with heart failure: a systematic, standardized comparison of available measures. Heart Fail Rev. 2014;19(3):359–67.CrossRefPubMed Garin O, Herdman M, Vilagut G, et al. Assessing health-related quality of life in patients with heart failure: a systematic, standardized comparison of available measures. Heart Fail Rev. 2014;19(3):359–67.CrossRefPubMed
12.
Zurück zum Zitat Patrick DL, Deyo RA. Generic and disease-specific measures in assessing health status and quality of life. Med Care. 1989;27(3 Suppl):S217–32.CrossRefPubMed Patrick DL, Deyo RA. Generic and disease-specific measures in assessing health status and quality of life. Med Care. 1989;27(3 Suppl):S217–32.CrossRefPubMed
13.
Zurück zum Zitat Rector TS, Kubo SH, Cohn JN. Patients’ self-assessment of their congestive heart failure. Part 2: content, reliability and validity of a new measure, The Minnesota Living with Heart Failure Questionnaire. Heart Failure. 1987;3:198–209. Rector TS, Kubo SH, Cohn JN. Patients’ self-assessment of their congestive heart failure. Part 2: content, reliability and validity of a new measure, The Minnesota Living with Heart Failure Questionnaire. Heart Failure. 1987;3:198–209.
14.
Zurück zum Zitat Bennett SJ, Oldridge NB, Eckert GJ, et al. Comparison of quality of life measures in heart failure. Nurs Res. 2003;52(4):207–16.CrossRefPubMed Bennett SJ, Oldridge NB, Eckert GJ, et al. Comparison of quality of life measures in heart failure. Nurs Res. 2003;52(4):207–16.CrossRefPubMed
15.
Zurück zum Zitat Garin O, Ferrer M, Pont A, et al. Evidence on the global measurement model of the Minnesota Living with Heart Failure Questionnaire. Qual Life Res. 2013;22(10):2675–84.CrossRefPubMed Garin O, Ferrer M, Pont A, et al. Evidence on the global measurement model of the Minnesota Living with Heart Failure Questionnaire. Qual Life Res. 2013;22(10):2675–84.CrossRefPubMed
16.
Zurück zum Zitat Ho CC, Clochesy JM, Madigan E, Liu CC. Psychometric evaluation of the Chinese version of the Minnesota Living with Heart Failure Questionnaire. Nurs Res. 2007;56(6):441–8.CrossRefPubMed Ho CC, Clochesy JM, Madigan E, Liu CC. Psychometric evaluation of the Chinese version of the Minnesota Living with Heart Failure Questionnaire. Nurs Res. 2007;56(6):441–8.CrossRefPubMed
17.
Zurück zum Zitat Middel B, Bouma J, de Jongste M, et al. Psychometric properties of the Minnesota Living with Heart Failure Questionnaire (MLHF-Q). Clin Rehabil. 2001;15(5):489–500.CrossRefPubMed Middel B, Bouma J, de Jongste M, et al. Psychometric properties of the Minnesota Living with Heart Failure Questionnaire (MLHF-Q). Clin Rehabil. 2001;15(5):489–500.CrossRefPubMed
18.
Zurück zum Zitat Munyombwe T, Hofer S, Fitzsimons D, et al. An evaluation of the Minnesota Living with Heart Failure Questionnaire using Rasch analysis. Qual Life Res. 2014;23(6):1753–65.CrossRefPubMed Munyombwe T, Hofer S, Fitzsimons D, et al. An evaluation of the Minnesota Living with Heart Failure Questionnaire using Rasch analysis. Qual Life Res. 2014;23(6):1753–65.CrossRefPubMed
19.
Zurück zum Zitat Naveiro-Rilo JC, Diez-Juárez DM, Romero BA, et al. Validation of the Minnesota living with heart failure questionnaire in primary care. Rev Esp Cardiol. 2010;63(12):1419–27.CrossRefPubMed Naveiro-Rilo JC, Diez-Juárez DM, Romero BA, et al. Validation of the Minnesota living with heart failure questionnaire in primary care. Rev Esp Cardiol. 2010;63(12):1419–27.CrossRefPubMed
20.
Zurück zum Zitat Pollock SG, Lystash J, Tedesco C, et al. Usefulness of bucindolol in congestive heart failure. Am J Cardiol. 1990;66(5):603–7.CrossRefPubMed Pollock SG, Lystash J, Tedesco C, et al. Usefulness of bucindolol in congestive heart failure. Am J Cardiol. 1990;66(5):603–7.CrossRefPubMed
21.
Zurück zum Zitat Lambrinou E, Kalogirou F, Lamnisos D, et al. Evaluation of the psychometric properties of the Greek version of the Minnesota Living With Heart Failure questionnaire. J Cardiopulm Rehabil Prev. 2013;33(4):229–33.CrossRefPubMed Lambrinou E, Kalogirou F, Lamnisos D, et al. Evaluation of the psychometric properties of the Greek version of the Minnesota Living With Heart Failure questionnaire. J Cardiopulm Rehabil Prev. 2013;33(4):229–33.CrossRefPubMed
22.
Zurück zum Zitat Bennet SJ, Oldridge NB, Eckert GJ, et al. Discriminant properties of commonly used quality of life measures in heart failure. Qual Life Res. 2002;11(4):349–59.CrossRefPubMed Bennet SJ, Oldridge NB, Eckert GJ, et al. Discriminant properties of commonly used quality of life measures in heart failure. Qual Life Res. 2002;11(4):349–59.CrossRefPubMed
23.
Zurück zum Zitat Supino PG, Borer JS, Franciosa JA, et al. Acceptability and psychometric properties of the Minnesota Living With Heart Failure Questionnaire among patients undergoing heart valve surgery: validation and comparison with SF-36. J Card Fail. 2009;15(3):267–77.CrossRefPubMed Supino PG, Borer JS, Franciosa JA, et al. Acceptability and psychometric properties of the Minnesota Living With Heart Failure Questionnaire among patients undergoing heart valve surgery: validation and comparison with SF-36. J Card Fail. 2009;15(3):267–77.CrossRefPubMed
24.
Zurück zum Zitat Gandek B, Ware JE, Aaronson NK, et al. Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol. 1998;51(11):1171–8.CrossRefPubMed Gandek B, Ware JE, Aaronson NK, et al. Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol. 1998;51(11):1171–8.CrossRefPubMed
25.
Zurück zum Zitat Ware Jr J, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34(3):220–33.CrossRefPubMed Ware Jr J, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34(3):220–33.CrossRefPubMed
26.
Zurück zum Zitat Alonso J, Prieto L, Anto JM. [The Spanish version of the SF-36 Health Survey (the SF-36 health questionnaire): an instrument for measuring clinical results]. Med Clin (Barc ). 1995;104(20):771–6. Alonso J, Prieto L, Anto JM. [The Spanish version of the SF-36 Health Survey (the SF-36 health questionnaire): an instrument for measuring clinical results]. Med Clin (Barc ). 1995;104(20):771–6.
27.
Zurück zum Zitat Batista-Foguet JM, Coenders G, Alonso J. [Confirmatory factor analysis. Its role on the validation of health related questionnaires]. Med Clin (Barc ). 2004;122 Suppl 1:21–7.CrossRef Batista-Foguet JM, Coenders G, Alonso J. [Confirmatory factor analysis. Its role on the validation of health related questionnaires]. Med Clin (Barc ). 2004;122 Suppl 1:21–7.CrossRef
28.
Zurück zum Zitat Devins GM, Dion R, Pelletier LG, et al. Structure of lifestyle disruptions in chronic disease: a confirmatory factor analysis of the Illness Intrusiveness Ratings Scale. Med Care. 2001;39(10):1097–104.CrossRefPubMed Devins GM, Dion R, Pelletier LG, et al. Structure of lifestyle disruptions in chronic disease: a confirmatory factor analysis of the Illness Intrusiveness Ratings Scale. Med Care. 2001;39(10):1097–104.CrossRefPubMed
29.
Zurück zum Zitat Hatcher L. Developing measurement models with confirmatory factor analysis. In: A Step-by-Step Approach to Using the SAS System for Factor Analysis and Structural Equation Modelling. Cary, NC: 1994. Hatcher L. Developing measurement models with confirmatory factor analysis. In: A Step-by-Step Approach to Using the SAS System for Factor Analysis and Structural Equation Modelling. Cary, NC: 1994.
30.
Zurück zum Zitat Mulaik SA. Evaluation of goodness-of-fit indices for structural equation models. Psychol Bull. 1989;105:430–45.CrossRef Mulaik SA. Evaluation of goodness-of-fit indices for structural equation models. Psychol Bull. 1989;105:430–45.CrossRef
31.
Zurück zum Zitat Muthén LK, Muthén BO. Mplus user’s guide (6th ed ed.). Los Angeles: Muthén & Muthén; 1998. Muthén LK, Muthén BO. Mplus user’s guide (6th ed ed.). Los Angeles: Muthén & Muthén; 1998.
32.
Zurück zum Zitat Cook KF, Teal CR, Bjorner JB, et al. IRT health outcomes data analysis project: an overview and summary. Qual Life Res. 2007;16 Suppl 1:121–32.CrossRefPubMed Cook KF, Teal CR, Bjorner JB, et al. IRT health outcomes data analysis project: an overview and summary. Qual Life Res. 2007;16 Suppl 1:121–32.CrossRefPubMed
33.
Zurück zum Zitat Gomez R. Item response theory analyses of adult self-ratings of the ADHD symptoms in the Current Symptoms Scale. Assessment. 2011;18(4):476–86.CrossRefPubMed Gomez R. Item response theory analyses of adult self-ratings of the ADHD symptoms in the Current Symptoms Scale. Assessment. 2011;18(4):476–86.CrossRefPubMed
34.
Zurück zum Zitat Reeve BB, Hays RD, Bjorner JB, et al. Psychometric evaluation and calibration of health-related quality of life item banks: plans for the Patient-Reported Outcomes Measurement Information System (PROMIS). Med Care. 2007;45(5 Suppl 1):S22–31.CrossRefPubMed Reeve BB, Hays RD, Bjorner JB, et al. Psychometric evaluation and calibration of health-related quality of life item banks: plans for the Patient-Reported Outcomes Measurement Information System (PROMIS). Med Care. 2007;45(5 Suppl 1):S22–31.CrossRefPubMed
35.
Zurück zum Zitat Wright B, Stone M. Best test design: Rasch measurement. Chicago: MESA Press; 1979. Wright B, Stone M. Best test design: Rasch measurement. Chicago: MESA Press; 1979.
36.
Zurück zum Zitat Rasch G. Probabilistic models for some intelligence and attainment tests. Chicago: University of Chicago Press; 1960. Rasch G. Probabilistic models for some intelligence and attainment tests. Chicago: University of Chicago Press; 1960.
37.
Zurück zum Zitat Streiner D, Norman G. Health Measurement Scales. Oxford: Oxfors University Press; 1989. Streiner D, Norman G. Health Measurement Scales. Oxford: Oxfors University Press; 1989.
38.
Zurück zum Zitat Tesio L. Measuring behaviours and perceptions: Rasch analysis as a tool for rehabilitation research. J Rehabil Med. 2003;35(3):105–15.CrossRefPubMed Tesio L. Measuring behaviours and perceptions: Rasch analysis as a tool for rehabilitation research. J Rehabil Med. 2003;35(3):105–15.CrossRefPubMed
39.
Zurück zum Zitat Linacre J. A User’s Guide to WINSTEP. Chicago: MESA Press; 2009. Linacre J. A User’s Guide to WINSTEP. Chicago: MESA Press; 2009.
40.
Zurück zum Zitat Davidson M, Keating JL, Eyres S. A low back-specific version of the SF-36 Physical Functioning scale. Spine (Phila Pa 1976). 2004;29(5):586–94.CrossRef Davidson M, Keating JL, Eyres S. A low back-specific version of the SF-36 Physical Functioning scale. Spine (Phila Pa 1976). 2004;29(5):586–94.CrossRef
42.
Zurück zum Zitat Cronbach LJ. Coefficient alpha and the internal structure of test. Psychometrika. 1951;16:297–334.CrossRef Cronbach LJ. Coefficient alpha and the internal structure of test. Psychometrika. 1951;16:297–334.CrossRef
43.
Zurück zum Zitat Nunnally JC, Bernstein IH. Psychometric Theory. 3rd ed. New York: McGraw-Hill; 1994. Nunnally JC, Bernstein IH. Psychometric Theory. 3rd ed. New York: McGraw-Hill; 1994.
44.
Zurück zum Zitat Hak T, Willems D, van der Wal G, Visser F. A qualitative validation of the Minnesota Living with Heart Failure Questionnaire. Qual Life Res. 2004;13(2):417–26.CrossRefPubMed Hak T, Willems D, van der Wal G, Visser F. A qualitative validation of the Minnesota Living with Heart Failure Questionnaire. Qual Life Res. 2004;13(2):417–26.CrossRefPubMed
Metadaten
Titel
The Minnesota living with heart failure questionnaire: comparison of different factor structures
verfasst von
Amaia Bilbao
Antonio Escobar
Lidia García-Perez
Gemma Navarro
Raul Quirós
Publikationsdatum
01.12.2016
Verlag
BioMed Central
Erschienen in
Health and Quality of Life Outcomes / Ausgabe 1/2016
Elektronische ISSN: 1477-7525
DOI
https://doi.org/10.1186/s12955-016-0425-7

Weitere Artikel der Ausgabe 1/2016

Health and Quality of Life Outcomes 1/2016 Zur Ausgabe